Search clinical trials for: CLL, real-world evidence, acalabrutinib
Total 227 results
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Safety and Tolerability | Compare SHINGRIX Vaccine Response RatesUnited States
-
TG Therapeutics, Inc.Terminated
-
Zhongda HospitalCompletedHepatocellular CarcinomaChina
-
BayerCompletedLiver NeoplasmsUnited States, Canada, Japan, Spain, Sweden, Belgium, Argentina, Austria, Greece, Italy, Korea, Republic of, Netherlands, Russian Federation, Taiwan, Turkey, China, Denmark, Egypt, France, Saudi Arabia, Thailand
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon-small Cell Lung Cancer | Anaplastic Lymphoma Kinase Gene MutationFrance
-
AstraZenecaCompletedChronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell LymphomaIndia
-
Joseph B. Ciolino, MDUnited States Department of DefenseCompletedKeratolysisUnited States
-
Seoul National University HospitalCompletedNon-hodgkin Lymphoma,B CellKorea, Republic of
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisThailand
-
AstraZenecaActive, not recruitingPhase I: Relapsed or Refractory B-cell Malignancies | Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma | Phase II Cohort B: Relapsed or Refractory Chronic Lymphocytic LeukemiaChina
-
Inhye AhnBayerWithdrawnChronic Lymphocytic Leukemia (CLL)
-
University Hospital, MontpellierCompleted
-
University of MiamiAstraZenecaTerminatedMarginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Small Lymphocytic LeukemiaUnited States
-
PETHEMA FoundationActive, not recruitingChronic Lymphocytic Leukemia- Binet Staging SystemSpain
-
Acerta Pharma BVAstraZenecaCompletedDiffuse Large B Cell Lymphoma | NHL | Non-hodgkin's Lymphoma | DLBCLUnited States, United Kingdom
-
Fujian Medical UniversityCompleted
-
AstraZenecaCompletedBioequivalenceUnited States
-
Novartis PharmaceuticalsCompletedAllergic AsthmaUnited States
-
Narendranath EpperlaWithdrawnRecurrent Marginal Zone Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Nodal Marginal Zone Lymphoma | Recurrent Nodal Marginal Zone Lymphoma | Recurrent Splenic Marginal Zone Lymphoma | Refractory Splenic Marginal Zone Lymphoma and other conditions
-
SanofiCompleted
-
Weill Medical College of Cornell UniversityAstraZenecaWithdrawnChronic Lymphocytic Leukemia | CLL/SLLUnited States
-
Guangdong Provincial People's HospitalFirst Affiliated Hospital, Sun Yat-Sen University; Shenzhen People's Hospital; Affiliated Cancer Hospital & Institute of Guangzhou Medical University and other collaboratorsCompleted
-
Shin MineishiMilton S. Hershey Medical CenterWithdrawn
-
University of the PhilippinesCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHepatitis | Safety and TolerabilityUnited States
-
Acerta Pharma BVCompleted
-
Duchesnay Inc.Premier Research Group plcCompletedNausea and Vomiting of PregnancyUnited States
-
Acerta Pharma BVAstraZenecaTerminated
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
IVFarma LLCInstitute for Preventive and Social MedicineCompletedFertility Issues | Fertility Disorders | IVF | Gynecologic Disease | Reproductive Issues | Reproductive DisorderRussian Federation
-
National Institute of Allergy and Infectious Diseases...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Clinical...CompletedDiabetes Mellitus, Type ISweden, Norway
-
AstraZenecaAcerta Pharma BVCompletedCOVID-19Italy, Turkey, Brazil, Japan, South Africa, Germany, Poland, Russian Federation, India, Peru, France, Argentina, Chile, Mexico
-
AstraZenecaAcerta Pharma BVCompleted
-
Acerta Pharma BVAstraZenecaCompletedHepatic Insufficiency | Healthy Subjects | Hepatic ImpairmentUnited States
-
Augusta UniversityActive, not recruitingPreDiabetes | Metabolic Syndrome, Protection AgainstUnited States
-
Acerta Pharma BVCompletedA Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196Healthy ParticipantsUnited States
-
Acerta Pharma BVCompletedHealthy VolunteersUnited States
-
Acerta Pharma BVCompletedHealthy ParticipantsUnited States
-
Acerta Pharma BVCompletedHealthy VolunteersUnited States
-
The University of The West IndiesUnknown
-
Acerta Pharma BVCompleted
-
Acerta Pharma BVCompletedHepatic InsufficiencyUnited States
-
Acerta Pharma BVCompletedHealthy VolunteersUnited States
-
AstraZenecaAcerta Pharma, LLCCompletedBioavailability | B-cell Lymphoid CancerUnited States
-
Acerta Pharma BVTerminatedDLBCL | Richter SyndromeUnited Kingdom, United States
-
AstraZenecaParexelCompletedCOVID-19 | Mantle Cell LymphomaGermany
-
AstraZenecaAcerta Pharma BVCompleted
-
Acerta Pharma BVAcerta Pharma, LLCCompletedMultiple Myeloma (MM)United States, United Kingdom
-
AstraZenecaAcerta Pharma, LLCCompletedPharmacokinetics | BioavailabilityUnited States
-
ahmed nagy shaker ramadanCompletedInduction of Labor Affected Fetus / Newborn | Rupture of Membranes Prior to Onset of LaborEgypt